Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
Condition(s):Castration-resistant Prostate CancerLast Updated:December 9, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Castration-resistant Prostate CancerLast Updated:December 9, 2020Completed
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:January 17, 2024Recruiting
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:November 26, 2021Recruiting
Condition(s):Prostate CancerLast Updated:June 6, 2023Recruiting
Condition(s):Castration-Resistant Prostatic CancerLast Updated:February 26, 2024Available
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:December 13, 2023Completed
Condition(s):Bone Metastases; Castration-Resistant Prostate CancerLast Updated:January 4, 2017Completed
Condition(s):Castration-Resistant Prostatic NeoplasmsLast Updated:February 25, 2022Completed
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:March 28, 2024Active, not recruiting
Condition(s):Castration-Resistant Prostatic CancerLast Updated:November 29, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.